CVSI

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 7/11/2017
Contact Info
  • 2688 South Rainbow Boulevard
  • Suite B
  • Las Vegas, NV 89146

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2017 10-Q
CIK 0001510964
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2010
Employees 40 a/o Jul 10, 2017
Company Officers/Contacts
Michael Mona, Jr. President, CEO
Joseph Dowling CFO, Secretary
Company Directors
Michael Mona, Jr. Chairman
James McNulty Independent Director, Audit Committee Member, Compensation Committee Member
Stephen Schmitz Independent Director
Gary Sligar Independent Director, Audit Committee Member
Service Providers
Accounting/Auditing Firm
Tanner LLC
215 South State St.
Suite 800
Salt Lake City, UT, 84111
United States
 
Securities Counsel
Procopio, Cory, Hargreaves & Savitch LLP.
525 B Street, Suite 2200
San Diego, CA, 92101
United States
 
Investor Relations Firm
IRTH Communications, LLC
520 Broadway
Suite 350
Santa Monica, CA, 90401
United States
 
Company History
  • Formerly=CannaVest Corp. until 6-2016
  • Note = Company incorporated in Texas until 8-2013
  • Formerly=Foreclosure Solutions, Inc. until 3-2013
CVSI Security Details
Share Structure
Market Value1 $25,796,081 a/o Dec 12, 2017
Authorized Shares 190,000,000 a/o Jul 10, 2017
Outstanding Shares 90,512,565 a/o Nov 07, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 20,890,348 a/o Jul 10, 2017
Par Value 0.0001
Transfer Agent(s)
Interwest Transfer Co., Inc.
Shareholders
Shareholders of Record 18,000 a/o Jul 10, 2017
Short Selling Data
Short Interest 30,525 (-12.98%)
Nov 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security